Archive

Martina Pigazzi, PhD, is Associate Professor at Woman and Child health Department, Onco-Hematology Clinic and Lab at the University of Padova. From 2008 she is the geneticist responsible for the diagnosis of all hematological disorders at her institute, and she is in charge of the...

Annita Montepeloso, PhD, is a senior researcher with over 10 years of experience in the field of hematopoietic stem and progenitor cell (HSPC) gene therapy for neurodegenerative and neurometabolic diseases.  She developed her carrier working at the San Raffaele Telethon Institute for Gene Therapy in...

Rita Milazzo, PhD, is a senior researcher with over 15 years of experience in the field of hematopoietic stem and progenitor cell (HSPC) gene therapy for neurodegenerative and autoimmune diseases. She developed her carrier working at the San Raffaele Telethon Institute for Gene Therapy in Milano,...

Moufida Ben Nasr M, PhD, is an immunologist. She is Research Fellow at Nephrology Division, Boston Children’s Hospital, Harvard Medical School. She published over 20 peer-reviewed manuscripts. She is focused in immunology and stem cell biology to develop strategies for transplantation and the treatment of hematological...

Paolo Fiorina, MD, PhD is an endocrinologist. He is Director, International Center for T1D, Romeo ed Enrica Invernizzi Pediatric, University of Milan, Italy; Professor of Endocrinology, L. Sacco Hospital, University of Milan; Chief of Division of Endocrinology, ASST Sacco-Fatebenefratelli, Milan, Italy and Lecturer on Pediatrics,...

Alessandra Biffi, MD, is a pediatric hematologist and stem cell transplant physician. She is Professor of Pediatrics, University of Padua and Chief of the Pediatric Onco-hematology Unit of Padua Hospital; until September 2018, Director of the Gene Therapy Program, Dana-Farber/Boston Children’s Cancer and Blood Disorders...

Pierluigi Paracchi, MEc, is co-Founder and Venture Consultant of AurorA-TT, a technology transfer initiative fully focused in the biotech sector, and co-Founder, board member and Strategy Consultant of Altheia Science. He has more than 15 years of experience as venture capitalist and biotech entrepreneur. He was...

Paolo Rizzardi, MD, internist, is co-Founder, Chairman&CEO of Altheia Science, a clinical-ready SME developing innovative gene therapy approaches in autoimmunity and cancer. He combines a strong scientific background with managerial skills gained in substantially contributing to successfully develop biotechnology companies and to achieve the market...